[
  {
    "ts": null,
    "headline": "Truist Lifts Fifth Third (FITB) Target After Strong Q4 but Trims FY26 EPS View",
    "summary": "Fifth Third Bancorp (NASDAQ:FITB) is included among the 14 High Yield Dividend Stocks with Sustainable Payouts. On January 26, Truist lifted its price objective on Fifth Third Bancorp (NASDAQ:FITB) to $60 from $55 and kept a Buy rating after the bank posted a stronger-than-expected Q4. The firm did lower its FY26 EPS estimate by $0.10 […]",
    "url": "https://finnhub.io/api/news?id=f9935179b8c86890bbe462829a8ba11dc285922ecd32cf5f148f1012995f3188",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769810450,
      "headline": "Truist Lifts Fifth Third (FITB) Target After Strong Q4 but Trims FY26 EPS View",
      "id": 138310384,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Fifth Third Bancorp (NASDAQ:FITB) is included among the 14 High Yield Dividend Stocks with Sustainable Payouts. On January 26, Truist lifted its price objective on Fifth Third Bancorp (NASDAQ:FITB) to $60 from $55 and kept a Buy rating after the bank posted a stronger-than-expected Q4. The firm did lower its FY26 EPS estimate by $0.10 […]",
      "url": "https://finnhub.io/api/news?id=f9935179b8c86890bbe462829a8ba11dc285922ecd32cf5f148f1012995f3188"
    }
  },
  {
    "ts": null,
    "headline": "Truist Reduces PT on American Healthcare REIT (AHR) Stock",
    "summary": "American Healthcare REIT, Inc. (NYSE:AHR) is one of the High-Flying Stocks to Buy Right Now. On January 20, Truist analyst Michael Lewis reduced its price objective on the company’s stock to $52 from $53, while keeping a “Buy” rating, as reported by The Fly. Notably, the firm made adjustments in the ratings and targets across the broader […]",
    "url": "https://finnhub.io/api/news?id=9c40ce20f5b942316572dd0938dce771e49b6971e139a1ecc4a31ee6ef1f5907",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769807117,
      "headline": "Truist Reduces PT on American Healthcare REIT (AHR) Stock",
      "id": 138310385,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "American Healthcare REIT, Inc. (NYSE:AHR) is one of the High-Flying Stocks to Buy Right Now. On January 20, Truist analyst Michael Lewis reduced its price objective on the company’s stock to $52 from $53, while keeping a “Buy” rating, as reported by The Fly. Notably, the firm made adjustments in the ratings and targets across the broader […]",
      "url": "https://finnhub.io/api/news?id=9c40ce20f5b942316572dd0938dce771e49b6971e139a1ecc4a31ee6ef1f5907"
    }
  },
  {
    "ts": null,
    "headline": "Charlotte region shines on national stage as corporate powerhouse",
    "summary": "A recent report shows Charlotte-based companies dominated the stock market last year, and new Charlotte Regional Business Alliance data helps explain why the region stands out.",
    "url": "https://finnhub.io/api/news?id=0062b5cff6294edb47e57fbe33ec6ce3eae850ff31ecf57bc842ec083556124c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769796960,
      "headline": "Charlotte region shines on national stage as corporate powerhouse",
      "id": 138309006,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "A recent report shows Charlotte-based companies dominated the stock market last year, and new Charlotte Regional Business Alliance data helps explain why the region stands out.",
      "url": "https://finnhub.io/api/news?id=0062b5cff6294edb47e57fbe33ec6ce3eae850ff31ecf57bc842ec083556124c"
    }
  },
  {
    "ts": null,
    "headline": "What Are Wall Street Analysts' Target Price for VICI Properties Stock?",
    "summary": "VICI Properties has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=593fd106252db56709c11203c21d442efd6c82f6422b5754682a0713c2c3d6be",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769785028,
      "headline": "What Are Wall Street Analysts' Target Price for VICI Properties Stock?",
      "id": 138307474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "VICI Properties has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=593fd106252db56709c11203c21d442efd6c82f6422b5754682a0713c2c3d6be"
    }
  },
  {
    "ts": null,
    "headline": "Truist Maintains Buy Rating on DLocal (DLO) Expecting Solid Q4 Performance Despite Challenging Volume Comparisons",
    "summary": "DLocal Limited (NASDAQ:DLO) is one of the best performing new tech stocks to buy now. On January 20, Truist raised its price target for DLocal to $17 from its previous target of $16 while maintaining a Buy rating. This adjustment was posted ahead of the company’s Q4 2025 earnings report, as part of a research […]",
    "url": "https://finnhub.io/api/news?id=9aa1136786f37e8df50247447c21c80181e9e01c6c5408811b32768c969c10ae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769784523,
      "headline": "Truist Maintains Buy Rating on DLocal (DLO) Expecting Solid Q4 Performance Despite Challenging Volume Comparisons",
      "id": 138306321,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "DLocal Limited (NASDAQ:DLO) is one of the best performing new tech stocks to buy now. On January 20, Truist raised its price target for DLocal to $17 from its previous target of $16 while maintaining a Buy rating. This adjustment was posted ahead of the company’s Q4 2025 earnings report, as part of a research […]",
      "url": "https://finnhub.io/api/news?id=9aa1136786f37e8df50247447c21c80181e9e01c6c5408811b32768c969c10ae"
    }
  },
  {
    "ts": null,
    "headline": "Turist Financial Remains a Buy on Nuvation Bio (NUVB)",
    "summary": "​Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 27, Gregory Renza from Turist Financial reiterated a Buy rating on the stock and raised the price target from $11 to $13. Earlier on January 23, Soumit Roy from JonesTrading assigned a Buy rating on Nuvation […]",
    "url": "https://finnhub.io/api/news?id=6c1fb6764f88e589198160ccb48e356649885f7e6fdc3b62a6aa192d8c791176",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769784438,
      "headline": "Turist Financial Remains a Buy on Nuvation Bio (NUVB)",
      "id": 138306322,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "​Nuvation Bio Inc. (NYSE:NUVB) is one of the Best Small Cap Stocks Ready to Explode in 2026. On January 27, Gregory Renza from Turist Financial reiterated a Buy rating on the stock and raised the price target from $11 to $13. Earlier on January 23, Soumit Roy from JonesTrading assigned a Buy rating on Nuvation […]",
      "url": "https://finnhub.io/api/news?id=6c1fb6764f88e589198160ccb48e356649885f7e6fdc3b62a6aa192d8c791176"
    }
  },
  {
    "ts": null,
    "headline": "Do Conflicting Wall Street Views Reveal Something Deeper About CCC Intelligent Solutions’ (CCC) Profit Potential?",
    "summary": "Recently, CCC Intelligent Solutions Holdings Inc. drew fresh Wall Street attention as Truist and Goldman Sachs both initiated analyst coverage, offering contrasting views on its margin outlook and growth trajectory. This split between bullish and more cautious assessments highlights how differently investors may interpret CCC’s data-driven business model and its position in the auto insurance claims ecosystem. Next, we’ll examine how this divergence in analyst opinions around CCC’s growth...",
    "url": "https://finnhub.io/api/news?id=eae903e33304b1a8271d69b58a5111205d712a6a6ecdb6005cc71e63ba667cf8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769778775,
      "headline": "Do Conflicting Wall Street Views Reveal Something Deeper About CCC Intelligent Solutions’ (CCC) Profit Potential?",
      "id": 138305498,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Recently, CCC Intelligent Solutions Holdings Inc. drew fresh Wall Street attention as Truist and Goldman Sachs both initiated analyst coverage, offering contrasting views on its margin outlook and growth trajectory. This split between bullish and more cautious assessments highlights how differently investors may interpret CCC’s data-driven business model and its position in the auto insurance claims ecosystem. Next, we’ll examine how this divergence in analyst opinions around CCC’s growth...",
      "url": "https://finnhub.io/api/news?id=eae903e33304b1a8271d69b58a5111205d712a6a6ecdb6005cc71e63ba667cf8"
    }
  },
  {
    "ts": null,
    "headline": "Amer Sports (AS) EPS Forecast Exceeds $2.50 by 2030, Says Truist",
    "summary": "Amer Sports Inc. (NYSE:AS) ranks among the best high growth European stocks to buy. On January 14, Truist Securities raised its price target for Amer Sports Inc. (NYSE:AS) to $46 from $45, while keeping a Buy rating on the company’s shares. The firm noted “durable growth levers across the business” as its main justification for […]",
    "url": "https://finnhub.io/api/news?id=10084f61118dafb75041c2eae7d5ebe7f40c8eee848e92715d38aff14d05be89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769756822,
      "headline": "Amer Sports (AS) EPS Forecast Exceeds $2.50 by 2030, Says Truist",
      "id": 138303598,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Amer Sports Inc. (NYSE:AS) ranks among the best high growth European stocks to buy. On January 14, Truist Securities raised its price target for Amer Sports Inc. (NYSE:AS) to $46 from $45, while keeping a Buy rating on the company’s shares. The firm noted “durable growth levers across the business” as its main justification for […]",
      "url": "https://finnhub.io/api/news?id=10084f61118dafb75041c2eae7d5ebe7f40c8eee848e92715d38aff14d05be89"
    }
  },
  {
    "ts": null,
    "headline": "Truist Highlights Nuvation Bio’s (NUVB) Ibtrozi’s Robust Market Uptake and Lead Over Competitors",
    "summary": "Nuvation Bio Inc. (NYSE:NUVB) is one of the best high short interest stocks with biggest upside potential. On January 27, Truist raised its price target on Nuvation Bio to $13 from $11 and maintained a Buy rating, citing the Ibtrozi franchise’s robust initial performance as part of a Q4 2025 earnings preview for the biotech […]",
    "url": "https://finnhub.io/api/news?id=a32d87d5c0b4717d1184f48e23e50f7a6ee3ee4454da51f7774260de28419c7d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769750656,
      "headline": "Truist Highlights Nuvation Bio’s (NUVB) Ibtrozi’s Robust Market Uptake and Lead Over Competitors",
      "id": 138303599,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TFC",
      "source": "Yahoo",
      "summary": "Nuvation Bio Inc. (NYSE:NUVB) is one of the best high short interest stocks with biggest upside potential. On January 27, Truist raised its price target on Nuvation Bio to $13 from $11 and maintained a Buy rating, citing the Ibtrozi franchise’s robust initial performance as part of a Q4 2025 earnings preview for the biotech […]",
      "url": "https://finnhub.io/api/news?id=a32d87d5c0b4717d1184f48e23e50f7a6ee3ee4454da51f7774260de28419c7d"
    }
  }
]